Orange Book product · Brand (NDA)
DYLOJECT
DICLOFENAC SODIUM
At a glance
Dec 23, 2014
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 23, 2014
11 yr 8 mo ago
Today
Patent 8946292 expires
Listed method-of-use patent (U-1659) expiration.
Mar 22, 2027
in 9 mo
Pharmaceutical detail
Active ingredient
DICLOFENAC SODIUM
Strength
37.5MG/ML (37.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
Not listed
Application
NDA 022396
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2014PENNSAIDBrand (NDA)
NDA 204623 · HORIZON
- 2009PENNSAIDBrand (NDA)
NDA 020947 · NUVO PHARMS INC
- 2007VOLTAREN ARTHRITIS PAINBrand (NDA)
NDA 022122 · HALEON US HOLDINGS
- 2000SOLARAZEBrand (NDA)
NDA 021005 · FOUGERA PHARMS
- 1998DICLOFENAC SODIUMBrand (NDA)
NDA 020809 · FALCON PHARMS
- 1991VOLTARENBrand (NDA)
NDA 020037 · NOVARTIS
- 2025DICLOFENAC SODIUMGeneric (ANDA)
ANDA 217646 · ENCUBE
- 2023DICLOFENAC SODIUMGeneric (ANDA)
ANDA 213040 · AUROLIFE PHARMA LLC
- 2022DICLOFENAC SODIUMGeneric (ANDA)
ANDA 212506 · ALEMBIC
- 2022DICLOFENAC SODIUMGeneric (ANDA)
ANDA 208098 · SUN PHARMA CANADA
- 2022DICLOFENAC SODIUMGeneric (ANDA)
ANDA 208021 · LUPIN PHARMS
- 2022DICLOFENAC SODIUMGeneric (ANDA)
ANDA 208198 · AMNEAL
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8946292 | Mar 22, 2027 | in 9 mo | U-1659 |

